| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/02/2003 | EP1267798A1 Treatment of skin damage using polyenylphosphatidylcholine |
| 01/02/2003 | EP1267765A1 Antibiotic and antifungal compositions |
| 01/02/2003 | EP1267764A1 Transdermal patch comprising controlled heating device |
| 01/02/2003 | EP1267634A1 Digestable chewing gum |
| 01/02/2003 | EP1267626A1 Recombinant parainfluenza virus expression systems and vaccines |
| 01/02/2003 | EP1267622A2 Anthelmintic combinations |
| 01/02/2003 | EP1210944A4 Blood plasma replacement solution |
| 01/02/2003 | EP1139755A4 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 01/02/2003 | EP1113798B1 Topical formulation of alkyl-, phenyl-pyridone |
| 01/02/2003 | EP1105102B1 Pharmaceutical composition for injection based on a pharmaceutically acceptable clopidogrel or ticlopidin salt |
| 01/02/2003 | EP1098935B1 Coating and excipient agent for oral or dermal dosage forms |
| 01/02/2003 | EP1067901B1 Low residue cosmetic composition |
| 01/02/2003 | EP1061948B1 Sustained-release preparation of physiologically active polypeptide and production thereof |
| 01/02/2003 | EP0942714B1 A product, a method for its production, and its use |
| 01/02/2003 | EP0928195B1 Compositions for use in embolizing blood vessels |
| 01/02/2003 | EP0893999B8 Process for producing efonidipine hydrochloride preparations |
| 01/02/2003 | EP0863754B1 Hydrolysis-optimized lipid emulsions and use thereof |
| 01/02/2003 | EP0820276B1 Process for the preparation of respirable particles |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/02/2003 | EP0723440B1 Therapeutic delivery compositions and methods of use thereof |
| 01/02/2003 | EP0489119B2 Resuspendable coated magnetic particles and stable magnetic particle suspensions |
| 01/02/2003 | DE20215704U1 Flexible nasal plaster comprises a plug-like tampon for insertion to dilate the nostrils and a foam-like layer for releasing active agents into inhaled air |
| 01/02/2003 | CA2391753A1 Combination chemotherapy |
| 01/01/2003 | CN2528467Y Hepatinica medicine slow-released core adhesive |
| 01/01/2003 | CN2528443Y Two-sided coated adhesive plaster |
| 01/01/2003 | CN1388760A Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 01/01/2003 | CN1388759A Medicine containing Anemonin as effective component for treating aseptic inflammation |
| 01/01/2003 | CN1388758A Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 01/01/2003 | CN1388757A Bioavailable dosage form of isotretinoin |
| 01/01/2003 | CN1388190A Dis-coating composition containing starch or starch gum |
| 01/01/2003 | CN1388189A Dip-coating composition containing cellulose ether |
| 01/01/2003 | CN1387920A 粘性绷带 Adhesive bandage |
| 01/01/2003 | CN1387915A Plaster matrix and its prepn |
| 01/01/2003 | CN1387899A Externally applied ointment for treating burns and its prepn |
| 01/01/2003 | CN1387896A Compound seabuckthorn fruit oil suppository |
| 01/01/2003 | CN1387881A Externally applied Chinese medicine oil prepn for treating burns and scalds |
| 01/01/2003 | CN1387880A Blood circulation promoting wine |
| 01/01/2003 | CN1387879A Fase nursing and beautifying oral liquid and its prepn |
| 01/01/2003 | CN1387863A Prepn process and use of heat-resisting nutritious microcapsule fish oil DHA powder |
| 01/01/2003 | CN1387854A Dispersed general arasaponin tablet and its prepn and application |
| 01/01/2003 | CN1387847A Lefunomide plaster and its prepn |
| 01/01/2003 | CN1387844A Wide-spectrum externally applied venereal remedy |
| 01/01/2003 | CN1387842A Transdermal plaster of aryl propionic non-steroid antiphlogistic |
| 01/01/2003 | CN1387841A Method of preparing decoction with superfine Chinese medicine granule |
| 01/01/2003 | CN1387840A Prepn of superfine instant chinese medicine granule |
| 01/01/2003 | CN1387839A Magnetotherapeutic ointment |
| 01/01/2003 | CN1097619C Moisture barrier film coating composition, its producing method and coating products |
| 01/01/2003 | CN1097467C Vaccine compositions |
| 01/01/2003 | CN1097463C Method for preparing medicinal moxibustion materials extractive preparation for electrical moxibustion therapy |
| 01/01/2003 | CN1097461C Paste for treating child diarrhoea |
| 01/01/2003 | CN1097458C Stable oil-in-water emulsions containing taxine (taxol) and its producing process |
| 01/01/2003 | CN1097456C Method for manufacturing troche for eliminating gastrointestinal vesicle and its application |
| 01/01/2003 | CN1097455C New aqueous medicament preparation for the production of propellent gas-free acrosols |
| 12/31/2002 | USRE37950 Biogradable in-situ forming implants and methods of producing the same |
| 12/31/2002 | US6500930 Hemoglobin-polysaccharide conjugates |
| 12/31/2002 | US6500867 Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
| 12/31/2002 | US6500862 Nonsettling mixtures of oleic, linoleic and palmitoleic acids, diethylene glycol, diethyl ether, n-methylpyrrolidone, polyethers, sodium laury sulfate, isopropanol, water and attractants having storage stability and chemical resistance |
| 12/31/2002 | US6500861 Elimination of bacteria, spores and fungi from urogenital or gastrointerstinal systems by washing with mixtures of caproic, caprylic, capric, lauric, citric, acetic or fumaric acids, anionic surfactants and water |
| 12/31/2002 | US6500859 Administering microtubule stabilizing chemotherapeutic agent for prophylaxis of arterial disease |
| 12/31/2002 | US6500808 Anti-viral composition |
| 12/31/2002 | US6500777 Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions |
| 12/31/2002 | US6500469 Treating hypercholesterolemia with synergistic combination |
| 12/31/2002 | US6500467 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500466 Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use |
| 12/31/2002 | US6500463 Mixing plasticizable matrix material, liquid plasticizer, encapsulant, non-plasticizable non-gelatinized starch, and component for controlling rate of release of encapsulant under low shear and low temperature, forming into pieces, drying |
| 12/31/2002 | US6500462 Edible MCC/PGA coating composition |
| 12/31/2002 | US6500461 Core comprising poorly hydrophilic compound, conjugate of biocompatible hydrophilic domain and biocompatible hydrophobic domain, conjugate surrounding core |
| 12/31/2002 | US6500460 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 12/31/2002 | US6500459 Controlled onset and sustained release dosage forms and the preparation thereof |
| 12/31/2002 | US6500457 Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| 12/31/2002 | US6500456 Compressed nitroglycerin tablet and its method of manufacture |
| 12/31/2002 | US6500455 Coating crystalline, racemic tolperisone in coating column which is operated with air flow with mixture of methanol and solution of synthetic, semisynthetic or natural hydrogels in chloroform to produce delayed release preparation |
| 12/31/2002 | US6500454 Dosage form of timed, sustained release beads comprising core particle of propranolol coated with ethyl cellulose membrane to sustain drug release and outer membrane comprising mixture of ethyl cellulose and enteric polymer providing lag time |
| 12/31/2002 | US6500453 Drug delivery |
| 12/31/2002 | US6500449 Implanting in an eye of encapsulated cells which produce polypeptides that exhibit neurotrophic and/or antiangiogenic activity, such as fibroblast growth factor; encapsulation prevents immune reaction |
| 12/31/2002 | US6500448 Composition comprising biocompatible polymer matrix having particles of metal cation-complexed human growth hormone dispersed therein, and aqueous injection vehicle comprising low viscosity sodium carboxymethyl cellulose |
| 12/31/2002 | US6500447 pH-sensitive microcapsules |
| 12/31/2002 | US6500446 Composition for skin treatment comprising pharmaceutically or cosmetically acceptable medium with dispersed cationic polysaccharide and microparticles or nanoparticles containing at least one biologically active molecule; synergistic |
| 12/31/2002 | US6500443 Treatment combination for imparting liquid-mediated transfer medium to sheet material consisting essentially of surfactant and sacrificial substrate combined in aqueous emulsion |
| 12/31/2002 | US6500440 Preparation comprising alprostadil in oily vehicle with skin permeation enhancer, anti-irritant agent and thickener |
| 12/31/2002 | US6500432 Method to enhance an immune response of nucleic acid vaccination |
| 12/31/2002 | US6500431 Inhibitors of angiogenesis and tumor growth |
| 12/31/2002 | US6500424 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500423 Probiotic composition comprising viable escherichia coli strain bu-230-98 atcc deposit no. 20226 (dsm 12799) and a formulation for maintaining viability of said escherichia coli strain |
| 12/31/2002 | US6500411 A particulate material and a natural polymer free of carboxymethyl cellulose or xanthan gum for addtion to a formulation including a hydrophilic liquid selected from water, a hydrophilic organic liquid, and mixture; sunscreen |
| 12/31/2002 | US6500168 Substance delivery device |
| 12/31/2002 | US6499984 Continuous production of pharmaceutical granulation |
| 12/31/2002 | CA2281673C Methods for administering nutritional indium |
| 12/31/2002 | CA2274516C Process for the preparation of emulsified powders |
| 12/31/2002 | CA2097732C Composition comprising r-alpha-lipoic acid and vitamin e for treating diabetes mellitus |
| 12/31/2002 | CA2079443C Binding of growth hormone to liposomes |
| 12/31/2002 | CA2029524C Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole |
| 12/27/2002 | WO2002103014A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 12/27/2002 | WO2002102825A2 Fluorescently labelled locked nucleic acids |
| 12/27/2002 | WO2002102445A1 Dry powder inhalation system for transpulmonary administration |
| 12/27/2002 | WO2002102428A1 Synechia inhibitory material |
| 12/27/2002 | WO2002102415A1 Gastric floating system |
| 12/27/2002 | WO2002102414A1 Medicinal compositions |
| 12/27/2002 | WO2002102413A2 Alkali or alkaline earth metal benzoate particles |
| 12/27/2002 | WO2002102391A2 Composition comprising nanoparticulate spironolactone |